Acumen pharmaceuticals to report first quarter financial results on may 9, 2023

Charlottesville, va. and carmel, ind., may 02, 2023 (globe newswire) -- acumen pharmaceuticals, inc. (nasdaq: abos) (“acumen” or the “company”), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (aΒos) for the treatment of alzheimer's disease, today announced that the company will report first quarter financial results on tuesday, may 9, 2023. the company will host a conference call and live audio webcast at 8:00 a.m. et to provide a business and financial update.
ABOS Ratings Summary
ABOS Quant Ranking